“Leigh Charvet, PhD, New York University Grossman School of Medicine, New York, NY, discusses the RECOVER-NEURO clinical trial, which aims to investigate the effectiveness of various interventions in alleviating symptoms of cognitive dysfunction associated with long-COVID. As basic science research continues to unfold, there is an urgency to develop effective treatment for individuals currently living with long-COVID. RECOVER-NEURO will evaluate the use of Brain HQ, transcranial direct current stimulation (tDCS), and PASC cognitive recovery (PASC-CoRE), as treatments to improve cognitive function. Approximately 315 participants will be enrolled in a 10-week study. Prof. Charvet, study PI, highlights the contactless home-based treatment approach, highlighting the accessibility and nationwide reach of their program. As the trial progresses, the team is optimistic about identifying effective tools to aid recovery and enhance the well-being of those suffering with the cognitive challenges of long-COVID. This interview took place during the annual ACTRIMS Forum 2024.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved
